Pantoprazole

Overview

Pantoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach and is used to treat erosive esophagitis and other conditions involving excess stomach acid, such as Zollinger-Ellison syndrome. It is available as a generic medication and under various trade names worldwide.

API suppliers (68)

Suppliers of Pantoprazole backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• METROCHEM API PRIVATE LTD3 active DMF
• AZICO BIOPHORE INDIA PVT LTD2 active DMF
• VASUDHA PHARMA CHEM LTD2 active DMF
• Mankind Pharma LimitedIndia2 active DMF
• APITORIA PHARMA PRIVATE LTDIndia2 active DMF
• Dr. Reddy's Laboratories Ltd.India2 active DMF
• Sun Pharmaceutical Industries LimitedIndia2 active DMF
• ORBION PHARMACEUTICALS PRIVATE LTDIndia2 active DMF
• PMC ISOCHEMFrance1 active DMF
• Cipla USA, Inc.USA1 active DMF
• HOLIDAY LABS MEXICO SA DE CV1 active DMF
• TAPI NL BV1 active DMF
• PMC ISOCHEMFrance1 active DMF
• Cipla USA, Inc.USA1 active DMF
• HOLIDAY LABS MEXICO SA DE CV1 active DMF
• JUBILANT BIOSYS LTD1 active DMF
• Macleods Pharmaceuticals Ltd.India1 active DMF
• MOEHS IBERICA SLSpain1 active DMF
• PMC ISOCHEMFrance1 active DMF
• HOLIDAY LABS MEXICO SA DE CV1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• Wockhardt LimitedIndia1 active DMF
• TAPI NL BV1 active DMF
• Wockhardt LimitedIndia1 active DMF

Showing 25 of 68 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (51 approved US products), the latest listed US patent on Pantoprazole expires 7 Dec 2026 and exclusivity 11 Aug 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole

Canonical SMILES

COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC

InChIKey

IQPSEEYGBUAQFF-UHFFFAOYSA-N

Therapeutic areas